Featured Research

from universities, journals, and other organizations

Cancer tumours that fight themselves

Date:
April 30, 2010
Source:
Lund University
Summary:
Cancer cells producing toxins that destroy tumours – could this be a future treatment for cancer? Researchers in Sweden have achieved good results in tests on both cells and animals.

Cancer cells producing toxins that destroy tumours -- could this be a future treatment for cancer? Researchers at Lund University have achieved good results in tests on both cells and animals.

The results have now been presented in the respected scientific journal Cancer Research.

"We have previously discovered that a carbohydrate, xylose, linked to a naphthalene preferentially inhibits growth of tumour cells but not normal cells" says Katrin Mani.

This is something the researchers have been aware of for around 10 years. Since then, they have been working on the mechanism of action of the drug to try to understand why the xylose compound works so well against tumour cells.

Two research groups, led by Katrin Mani and Ulf Ellervik, have utilised natural biological processes and tested their ideas in animal experiments, which show up to 97% reduction in tumour growth. The researchers have found that when the cells are grown together with certain xylose-containing compounds, they begin to produce long carbohydrate chains called glycosaminoglycans (GAG). Different cell types produce different glycosaminoglycans, which are usually transported out of the cell.

"Glycosaminoglycans from normal cells are completely inactive. However, glycosaminoglycans from cancer cells are very active. They are quickly taken up by both normal and cancer cells and transported to the cell nuclei where they affect gene transcription and induce an antiproliferative effect, accompanied by apoptosis (cell death). The specific carbohydrate chains from tumour cells are in practice toxins," says Katrin Mani.

"Around the tumour, where there are lots of cancer cells, a high concentration of the toxin is built up. This means that the tumour produces a toxin that kills itself. When the tumour is gone, no more toxin will be produced," says Ulf Ellervik. It takes many years to develop an anticancer drug that can be used on patients. However, this is an important step on the way.

"So far all types of tumour we have tested have reacted in the same way and we are very hopeful for the future research results."


Story Source:

The above story is based on materials provided by Lund University. Note: Materials may be edited for content and length.


Journal Reference:

  1. U. Nilsson, R. Johnsson, L. A. Fransson, U. Ellervik, K. Mani. Attenuation of Tumor Growth by Formation of Antiproliferative Glycosaminoglycans Correlates with Low Acetylation of Histone H3. Cancer Research, 2010; DOI: 10.1158/0008-5472.CAN-09-4331

Cite This Page:

Lund University. "Cancer tumours that fight themselves." ScienceDaily. ScienceDaily, 30 April 2010. <www.sciencedaily.com/releases/2010/04/100429093603.htm>.
Lund University. (2010, April 30). Cancer tumours that fight themselves. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2010/04/100429093603.htm
Lund University. "Cancer tumours that fight themselves." ScienceDaily. www.sciencedaily.com/releases/2010/04/100429093603.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) — Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) — Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) — At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) — Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins